← All trials
NCT01780636
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2013
- Primary completion
- Jan 1, 2014
- Completion date
- Jul 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 30
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of California, IrvineLead sponsor
- University of California, IrvineOverall official - principal investigator
- University of California, IrvineReponsible party - principal investigator
- AllerganCollaborator
- American Urogynecologic SocietyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.